The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity

[1]  S. Thompson,et al.  Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  F. Rixon,et al.  Herpes Simplex Virus Type 1 Accumulation, Envelopment, and Exit in Growth Cones and Varicosities in Mid-Distal Regions of Axons , 2006, Journal of Virology.

[3]  S. Dunnett,et al.  HSV vector-delivery of GDNF in a rat model of PD: partial efficacy obscured by vector toxicity , 2004, Brain Research.

[4]  H. Federoff,et al.  HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury , 2003, Experimental Neurology.

[5]  H. Federoff,et al.  Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  D. Perkins,et al.  The Herpes Simplex Virus Type 2 R1 Protein Kinase (ICP10 PK) Functions as a Dominant Regulator of Apoptosis in Hippocampal Neurons Involving Activation of the ERK Survival Pathway and Upregulation of the Antiapoptotic Protein Bag-1 , 2003, Journal of Virology.

[7]  D. Perkins.  Targeting apoptosis in neurological disease using the herpes simplex virus , 2002, Journal of cellular and molecular medicine.

[8]  P. Yarowsky,et al.  The Herpes Simplex Virus Type 2 R1 Protein Kinase (ICP10 PK) Blocks Apoptosis in Hippocampal Neurons, Involving Activation of the MEK/MAPK Survival Pathway , 2002, Journal of Virology.

[9]  S. Asai,et al.  Effects of glutamate receptor agonist on extracellular glutamate dynamics during moderate cerebral ischemia , 2001, Brain Research.

[10]  R. Sapolsky,et al.  Gene therapy against neurological insults: sparing neurons versus sparing function , 2001, Trends in Neurosciences.

[11]  J. Glorioso,et al.  Bcl-2 and GDNF Delivered by HSV-Mediated Gene Transfer Act Additively to Protect Dopaminergic Neurons from 6-OHDA-Induced Degeneration , 2001, Experimental Neurology.

[12]  L. Aurelian,et al.  Ras-GAP Binding and Phosphorylation by Herpes Simplex Virus Type 2 RR1 PK (ICP10) and Activation of the Ras/MEK/MAPK Mitogenic Pathway Are Required for Timely Onset of Virus Growth , 2000, Journal of Virology.

[13]  L. Aurelian,et al.  Herpes simplex virus type 2 growth and latency reactivation by cocultivation are inhibited with antisense oligonucleotides complementary to the translation initiation site of the large subunit of ribonucleotide reductase (RR1). , 2000, Antisense & nucleic acid drug development.

[14]  Y. Mitsumoto,et al.  Adenovirus-Mediated Gene Transfer of Glial Cell Line-Derived Neurotrophic Factor Prevents Ischemic Brain Injury after Transient Middle Cerebral Artery Occlusion in Rats , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  E. Mackenzie,et al.  A Transforming Growth Factor-β Antagonist Unmasks the Neuroprotective Role of This Endogenous Cytokine in Excitotoxic and Ischemic Brain Injury , 1999 .

[16]  James N. Davis,et al.  BCL-2 Transduction, Using a Herpes Simplex Virus Amplicon, Protects Hippocampal Neurons from Transient Global Ischemia , 1999, Experimental Neurology.

[17]  L. Aurelian,et al.  The PK Domain of the Large Subunit of Herpes Simplex Virus Type 2 Ribonucleotide Reductase (ICP10) Is Required for Immediate-Early Gene Expression and Virus Growth , 1998, Journal of Virology.

[18]  R. Sapolsky,et al.  Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy , 1998, Annals of neurology.

[19]  R. Schwarcz,et al.  Dopaminergic Control of Kynurenate Levels and N-Methyl-D-Aspartate Toxicity in the Developing Rat Striatum , 1998, Developmental Neuroscience.

[20]  M. Moskowitz,et al.  Mechanisms of Reduced Striatal NMDA Excitotoxicity in Type I Nitric Oxide Synthase Knock-Out Mice , 1997, The Journal of Neuroscience.

[21]  L. Aurelian,et al.  The large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is associated with the virion tegument and has PK activity. , 1997, Virology.

[22]  B. Hoffer,et al.  Glial Cell Line-Derived Neurotrophic Factor Protects against Ischemia-Induced Injury in the Cerebral Cortex , 1997, The Journal of Neuroscience.

[23]  M. Moskowitz,et al.  [3H]L-NG-Nitroarginine Binding after Transient Focal Ischemia and NMDA-Induced Excitotoxicity in Type I and Type III Nitric Oxide Synthase Null Mice , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  S. L. Fink,et al.  Defective Herpes Simplex Virus Vectors Expressing the Rat Brain Stress‐Inducible Heat Shock Protein 72 Protect Cultured Neurons from Severe Heat Shock , 1997, Journal of neurochemistry.

[25]  G. Steinberg,et al.  Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  S. Lipton,et al.  Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function , 1995, Neuron.

[27]  M. Geschwind,et al.  Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. , 1995, Stroke.

[28]  A. Crossman,et al.  Acute and chronic behavioural sequelae resulting from intrastriatal injection of an NMDA agonist , 1994, Pharmacology Biochemistry and Behavior.

[29]  N. DeLuca,et al.  Gene transfer to brain using herpes simplex virus vectors , 1994, Annals of neurology.

[30]  J. Ordonez,et al.  The transmembrane domain of the large subunit of HSV-2 ribonucleotide reductase (ICP10) is required for protein kinase activity and transformation-related signaling pathways that result in ras activation. , 1994, Virology.

[31]  R. Neve,et al.  Molecular analysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vectors , 1991, Trends in Neurosciences.

[32]  T. Chung,et al.  Leucine repeats in the large subunit of herpes simplex virus type 2 ribonucleotide reductase (RR; ICP10) are involved in RR activity and subunit complex formation. , 1991, The Journal of general virology.

[33]  T. Chung,et al.  Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) , 1989, Journal of virology.

[34]  Roger B. H. Tootell,et al.  Modified technique for cytochrome oxidase histochemistry: increased staining intensity and compatibility with 2-deoxyglucose autoradiography , 1987, Journal of Neuroscience Methods.

[35]  O. Steward,et al.  Immunocytochemical localization of actin and microtubule-associated protein MAP2 in dendritic spines. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[36]  K. Fuxe,et al.  Rotational behaviour in rats with unilateral striatal kainic acid lesions: A behavioural model for studies on intact dopamine receptors , 1979, Brain Research.

[37]  S. T. Mason,et al.  Kainic acid lesions of the striatum: behavioural sequalae similar to Huntington's Chorea , 1978, Brain Research.

[38]  L. Aurelian.  HSV-induced apoptosis in herpes encephalitis. , 2005, Current topics in microbiology and immunology.

[39]  N. Conradi,et al.  Discrimination of herpes simplex virus types 1 and 2 cerebral infections in a rat model , 2004, Acta Neuropathologica.

[40]  S. Lipton.  Failures and successes of NMDA receptor antagonists: Molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults , 2004 .

[41]  R. Schwarcz,et al.  3-Hydroxykynurenine and quinolinate: pathogenic synergism in early grade Huntington's disease? , 2003, Advances in experimental medicine and biology.

[42]  E. Mackenzie,et al.  A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury. , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.